<html><head><title>2024-02-09</title><link rel="stylesheet" type="text/css" href="static/table.css"/></head><body><table id="container">
  <thead>
    <tr style="text-align: right;">
      <th role="columnheader">No.</th>
      <th role="columnheader">capSize</th>
      <th role="columnheader">stock</th>
      <th role="columnheader">chance</th>
      <th role="columnheader">risk</th>
      <th role="columnheader">tags</th>
      <th role="columnheader">Volatility</th>
      <th role="columnheader">YTD%</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>1</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/GM">GM<br>nan</a></td>
      <td>1. Toyota Motor stock has hit all-time highs.<br>2. Ford reported strong earnings and an upbeat 2024 profit outlook and said the company will keep spending more on its EV transformation.<br>3. The $19 billion deal between General Motors (GM) and LG Chem represents a landmark moment in the evolution of the EV industry.<br>4. General Motors on Thursday named former Tesla Inc executive Kurt Kelty to the newly created role of vice president of its battery unit.<br>5. Ford's CEO Jim Farley says the energy transition faces a new reality. Hybrid vehicles are here for the long run as customers gravitate towards choice and less expensive vehicles.<br>6. Today, Girl Scouts of the USA (GSUSA), the largest girl-led organization in the world, announces a new STEM Playbook, providing guidance, resources, and support to all staff, volunteers, and caregivers on how to continue sparking girls' interest in STEM. This playbook, supported by General Motors, provides adults with ideas to help create hands-on, exciting activities to engage their Girl Scouts in STEM.</td>
      <td>1. Ford Motor and General Motors have not hit all-time highs like Toyota Motor stock.<br>2. General Motors (GM) recalls more than 300,000 vehicles due to potential tailgate malfunction, which poses road hazards and crash risks.</td>
      <td>Stock Analysis<br>Automotive Industry<br>Electric Vehicles<br>Battery Technology<br>STEM Education</td>
      <td>286.84</td>
      <td>34.20</td>
    </tr>
    <tr>
      <td>2</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/AGL">AGL<br>agilon health</a></td>
      <td>1. agilon health, inc. has announced a comprehensive search process to identify a new Chief Medical Officer<br>2. The provider of support services for primary care physicians anticipates medical margins for fiscal 2023 of between $340 million and $360 million<br>3. The company has revised guidance expectations for 2023, reflecting higher-than-expected costs, and provided an initial outlook for 2024<br>4. agilon health, inc. will participate in the 42nd Annual J.P. Morgan Healthcare Conference including a fireside chat presentation<br>5. Insider buying can often provide valuable insights into a company's prospects and the confidence that insiders have</td>
      <td>1. Benjamin Kornitzer, M.D., will transition from his role as Chief Medical Officer (CMO) effective March 1, 2024<br>2. Timothy Bensley has informed the company of his intent to retire from his position as Chief Financial Officer (CFO) during 2024<br>3. The recent moves of three prominent companies that have sent ripples through the market may indicate underlying operational vulnerabilities<br>4. agilon health, inc.'s price-to-sales (P/S) ratio of 1.3x may pose a risk</td>
      <td>Healthcare<br>Management Changes<br>Financial Performance<br>Investor Relations<br>Market Participation</td>
      <td>562.40</td>
      <td>-37.42</td>
    </tr>
    <tr>
      <td>3</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/DAL">DAL<br>Delta Air Lines</a></td>
      <td>1. Robust air travel demand is expected to benefit Delta Air Lines (DAL) and other airline stocks<br>2. Delta Air Lines is expanding flights to tourist-friendly destinations in Latin America and the Caribbean, which could increase revenue<br>3. The commercial aerospace recovery is projected to continue in 2024, making it a great sector to invest in</td>
      <td>1. The transportation sector's fourth-quarter earnings have been unimpressive<br>2. The airplane manufacturing industry is facing challenges, which could indirectly impact airline stocks like DAL</td>
      <td>Airline Industry<br>Aerospace Sector<br>Commercial Aviation<br>Robust Travel Demand<br>Investment Opportunity</td>
      <td>290.30</td>
      <td>11.96</td>
    </tr>
    <tr>
      <td>4</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/UBER">UBER<br>Uber</a></td>
      <td>1. Uber's annualized gross bookings in its grocery and retail vertical reached $7 billion in the fourth quarter, showing strong growth potential<br>2. Uber reported its first full-year profit as a public company in 2023, reflecting positive financial performance<br>3. The company surpassed profit expectations for Q4 2023, with an EPS of $0.673 compared to expectations of $0.15<br>4. Investors applauded overall strength in U.S. earnings and the S&P 500 registered a record closing high</td>
      <td>1. Uber stock fell after the Q4 earnings report, indicating potential market volatility<br>2. The watered-down agreement on the rights of workers at Uber and Deliveroo in the EU could lead to regulatory challenges and labor issues<br>3. Competition in the ride-hailing and delivery market may pose challenges for Uber's growth and market share</td>
      <td>Tech<br>Earnings<br>Regulation<br>Ride-hailing<br>Delivery services</td>
      <td>1008.77</td>
      <td>27.40</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/IMGN">IMGN<br>ImmunoGen</a></td>
      <td>1. ImmunoGen has seen solid earnings estimate revision activity over the past two months,ImmunoGen (IMGN) might move higher on growing optimism about its earnings prospects<br>2. ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</td>
      <td>1. AbbVie Inc. announced its plans to acquire ImmunoGen in an all-cash transaction valued at roughly $10.1 billion.</td>
      <td>Biotech<br>Earnings<br>Acquisition<br>Medical Innovation</td>
      <td>649.96</td>
      <td>95.43</td>
    </tr>
    <tr>
      <td>6</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/VRT">VRT<br>Vertiv</a></td>
      <td>1. Vertiv Holdings Co. (VRT) closed at $61.67, indicating a +1.53% shift from the previous trading day.<br>2. Services activity in the United States is expanding, which is helping stocks like Vertiv Holdings Co (VRT).<br>3. The average brokerage recommendation (ABR) for Vertiv Holdings Co. (VRT) is equivalent to a Buy.</td>
      <td>1. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable.<br>2. It is worth exploring what lies ahead for the stock.</td>
      <td>VRT<br>Stock Analysis<br>Investment<br>Wall Street<br>Finance</td>
      <td>324.43</td>
      <td>46.03</td>
    </tr>
    <tr>
      <td>7</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/LVS">LVS<br>Las Vegas Sands</a></td>
      <td>1. Las Vegas Sands Corp. has been named one of Fortune's World's Most Admired Companies in 2024, indicating a strong reputation and respect within the global business community.<br>2. The company's full year 2023 results show a significant increase in revenue, up 152% from FY 2022, indicating strong financial performance.<br>3. Las Vegas Sands' fourth-quarter 2023 results reflect continued improvement in the operating environment in Macao and Singapore, potentially signaling ongoing growth and stability.</td>
      <td>1. The decline in revenue and EPS for Las Vegas Sands in the quarter ended December 2023, along with a surprise loss reported by Humana, suggests potential volatility and uncertainty in the market.<br>2. The warning from Tesla regarding slowing growth in 2024 may have broader implications for companies operating in related sectors, potentially impacting the overall market sentiment.</td>
      <td>Fortune 500<br>Financial Performance<br>Market Volatility<br>Global Expansion<br>Operational Improvement</td>
      <td>361.05</td>
      <td>12.96</td>
    </tr>
    <tr>
      <td>8</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/PATH">PATH<br>UiPath</a></td>
      <td>1. UiPath (PATH) concluded the recent trading session at $23.48, signifying a +1.43% move from its prior day's close.<br>2. Big tech crushed it in 2023; who will provide the next huge gains?<br>3. The market still has several fantastic stocks that can be purchased at a reasonable price.</td>
      <td>1. UiPath (PATH) closed the most recent trading day at $23.85, moving -1.41% from the previous trading session.<br>2. Just because the market is hitting new all-time highs doesn't mean you should quit buying.</td>
      <td>Tech Stocks<br>Growth<br>Artificial Intelligence<br>Automation<br>Financial Resilience</td>
      <td>387.32</td>
      <td>28.35</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/ET">ET<br>nan</a></td>
      <td>1. Australia’s Woodside Energy Group Ltd. is in talks to buy liquefied natural gas from several US export terminals, including Energy Transfer LP’s Lake Charles project in Louisiana,<br>2. The average brokerage recommendation (ABR) for Energy Transfer LP (ET) is equivalent to a Buy.<br>3. The Williams Companies (WMB) beat the Zacks Consensus Estimate for earnings in each of the last four quarters.<br>4. Oceaneering's (OII) Manufactured Products segment secures contracts worth approximately $200 million.<br>5. Imperial (IMO) expects production in the band of 420,000-442,000 barrels per day and 385,000-400,000 in the Upstream and Downstream segments, respectively, with capacity utilization of 89-92%.</td>
      <td>1. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable.<br>2. Nabors (NBR) expects capital expenditures in the range of $170-$180 million for the first quarter of 2024, with approximately $50 million designated for newbuilds in Saudi Arabia.<br>3. The chief executive officer of the country’s largest producer of natural gas dismissed the Biden administration’s move to freeze new liquefied natural gas exports as a political stunt, telling House lawmakers during a hearing Tuesday that the decision was designed to secure support at the ballot box.</td>
      <td>Energy<br>Transportation<br>Liquefied Natural Gas<br>Earnings<br>Production</td>
      <td>482.87</td>
      <td>4.12</td>
    </tr>
    <tr>
      <td>10</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/NKE">NKE<br>NIKE</a></td>
      <td>1. Nike (NKE) concluded the recent trading session at $103.79, signifying a +1.15% move from its prior day's close.<br>2. Barclays is reiterating its Overweight rating and $142 per share price target on Nike (NKE).<br>3. The company has declared a quarterly cash dividend of $0.370 per share, indicating stability and potential for returns for investors.<br>4. Retailers have slashed prices on twice as many Nike sneakers in 2024 than two years earlier, indicating potential challenges to the company's pricing power.</td>
      <td>1. The company faces competition from other sneaker brands, and retailers have been slashing prices on its products, impacting its pricing power.<br>2. There is a need for the company to introduce new and innovative products to attract consumers and maintain growth.<br>3. The recent arrest of the leader of an organized retail crime operation stealing and reselling Nike products raises concerns about the company's supply chain and security measures.</td>
      <td>Retail<br>Dividend<br>Competition<br>Stock Price<br>Innovation</td>
      <td>379.66</td>
      <td>-4.25</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/WBA">WBA<br>Walgreens Boots Alliance</a></td>
      <td>1. Walgreens Boots Alliance has made strategic executive appointments and updates to its healthcare and retail pharmacy services, indicating a proactive approach to turning around its stock performance.<br>2. The company's focus on its healthcare segment and cost structure alignment demonstrates a commitment to improving business performance and addressing waning demand for certain products.</td>
      <td>1. The stock has declined 38% in the last twelve months due to decreased demand for COVID products and personal care and beauty products, posing a risk to the company's financial performance.<br>2. State regulators have fined CVS for understaffing, highlighting the potential regulatory and operational risks faced by pharmacy chains.</td>
      <td>Healthcare<br>Retail Pharmacy<br>Executive Appointments<br>Cost Structure<br>Stock Performance</td>
      <td>284.20</td>
      <td>12.81</td>
    </tr>
    <tr>
      <td>12</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/SWN">SWN<br>nan</a></td>
      <td>1. SWN(Southwestern Energy Co.) is involved in the exploration and production of natural gas, oil, and NGLs, with operations in northeast Pennsylvania, West Virginia, and southwest Pennsylvania.<br>2. The company has recently been acquired by Chesapeake Energy Corporation, creating the dominant natural gas producer in the U.S.<br>3. The merger with Chesapeake Energy positions the combined company as a 'must own' for investors, providing exposure to two of the hottest themes in energy.</td>
      <td>1. The company's marketing segment is reliant on the marketing and transportation of natural gas, oil, and NGLs primarily produced in its exploration and production segment, making it susceptible to changes in demand and pricing.<br>2. Recent geopolitical tensions, including military airstrikes and vessel seizures, have the potential to impact global trade routes and the energy sector, affecting the company's operations and revenue.</td>
      <td>Energy Sector<br>Exploration and Production<br>Mergers and Acquisitions<br>Geopolitical Tensions<br>Natural Gas</td>
      <td>320.06</td>
      <td>-1.07</td>
    </tr>
    <tr>
      <td>13</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/ARDX">ARDX<br>Ardelyx</a></td>
      <td>1. Ardelyx (ARDX) has been upgraded to a Zacks Rank #2 (Buy), indicating growing optimism about its earnings prospects.<br>2. The biotech market is projected to experience robust growth from 2024 to 2030, with an expanding clinical trial pipeline and strong regulatory support for startups.</td>
      <td>1. Biotech stocks are part of a volatile and speculative industry, making them risky for average investors.<br>2. Stocks trading at a cheap price, such as below $10 per share, are inherently riskier than those with a strong financial position.</td>
      <td>Biotech<br>Pharmaceutical<br>Earnings prospects<br>Regulatory support<br>Volatility</td>
      <td>298.60</td>
      <td>126.65</td>
    </tr>
    <tr>
      <td>14</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/COP">COP<br>nan</a></td>
      <td>1. ConocoPhillips reported better-than-expected Q4 earnings, with higher oil equivalent production volumes<br>2. The company's pumping hours rose by more than 10% last year, aided by remote monitoring, quick drilling team movements, and electric fracking</td>
      <td>1. Decreased commodity prices may have negatively impacted ConocoPhillips' Q4 earnings<br>2. Jobless claims for the week ending February 3rd could slightly decrease, potentially affecting the oil and gas industry</td>
      <td>Oil and Gas Production<br>Earnings<br>Commodity Prices<br>Jobless Claims<br>Market Performance</td>
      <td>402.99</td>
      <td>-0.94</td>
    </tr>
    <tr>
      <td>15</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/IOVA">IOVA<br>Iovance Biotherapeutics</a></td>
      <td>1. Iovance's lead pipeline drug is anticipated to receive FDA approval as the first individualized, one-time cell therapy for certain patients with melanoma.<br>2. The company is focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.<br>3. Investment bank analysts are hyperbullish for Iovance's stocks, indicating positive market sentiment.</td>
      <td>1. Shares have dropped by double digits over the past three years, indicating a long-term downward trend.<br>2. The FDA placed a clinical hold on Iovance’s trial of a lung cancer treatment following the death of a patient, which may impact the company's future trials and approvals.<br>3. It will take a while for its risks to resolve, suggesting potential ongoing challenges for the company.</td>
      <td>FDA approval<br>clinical trials<br>investment bank analysis<br>cancer therapies<br>market sentiment</td>
      <td>314.09</td>
      <td>55.83</td>
    </tr>
    <tr>
      <td>16</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/CNHI">CNHI<br>CNH Industrial</a></td>
      <td>1. CNH Industrial (CNH) is committed to sustainability, innovation, and productivity, standing with farmers and construction workers.</td>
      <td>1. The Manufacturing - Farm Equipment industry is facing headwinds, which may impact CNH's performance.</td>
      <td>CNH Industrial<br>Farm Equipment<br>Sustainability<br>Innovation<br>Productivity</td>
      <td>393.85</td>
      <td>15.78</td>
    </tr>
    <tr>
      <td>17</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/SNOW">SNOW<br>Snowflake</a></td>
      <td>1. Snowflake's Cloud Data Platform has the potential to revolutionize the way businesses consolidate and analyze data.<br>2. The company's innovative technology and scalable architecture position it well for future growth and success.</td>
      <td>1. The controversial valuation of Snowflake stock may present a short-term risk for investors.<br>2. Mixed earnings results from tech giants and market fluctuations could impact Snowflake's stock performance.</td>
      <td>Cloud Data Platform<br>Innovative Technology<br>Scalable Architecture<br>Valuation Risk<br>Market Fluctuations</td>
      <td>302.00</td>
      <td>29.93</td>
    </tr>
    <tr>
      <td>18</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/CLF">CLF<br>Cleveland-Cliffs</a></td>
      <td>1. Cleveland-Cliffs (CLF) has gained strong momentum recently and is still trading at a reasonable price.<br>2. Shares of Cleveland-Cliffs (CLF) have started gaining and might continue moving higher in the near term.<br>3. The U.S. International Trade Commission voted to strike down anti-dumping duties on tin mill steel from Canada, China, Germany and South Korea, which could potentially benefit Cleveland-Cliffs (CLF).</td>
      <td>1. Former President Donald Trump has signaled concerns about U.S.-based companies being acquired by foreign entities, which could impact Cleveland-Cliffs (CLF) if similar sentiments gain traction.<br>2. There is uncertainty surrounding the steel industry after the acquisition of U.S. Steel Corp. by a Japanese steel powerhouse, which may have implications for companies like Cleveland-Cliffs (CLF).</td>
      <td>Steel Industry<br>Stock Momentum<br>Trade Commission Decision<br>Acquisition Concerns<br>Earnings Estimate Revisions</td>
      <td>334.13</td>
      <td>15.48</td>
    </tr>
    <tr>
      <td>19</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/LCID">LCID<br>Lucid</a></td>
      <td>1. Lucid Group Inc. stock has recently bounced back with a 25% increase, indicating a potential comeback.<br>2. The company's focus on making high-quality EVs is appealing to investors.</td>
      <td>1. The stock price has declined over 30% year-to-date, driven by underperformance on key metrics.<br>2. The company has lost well over 90% of its value in a little more than two years.</td>
      <td>EV<br>Stock Market<br>Electric Vehicles<br>Investing<br>Market Analysis</td>
      <td>333.02</td>
      <td>-20.23</td>
    </tr>
    <tr>
      <td>20</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/TSM">TSM<br>Taiwan Semiconductor Manufacturing Company</a></td>
      <td>1. The monthly revenue report from Taiwan Semiconductor Manufacturing could be a bullish sign for semiconductor investors.<br>2. The company's shares are higher on Hump Day, indicating encouraging news items.</td>
      <td>1. China has been trying to match Taiwan in chip technology, but hasn't succeeded yet despite investing huge sums.<br>2. There is continued weakness in consumer electronics products, despite strong demand for AI chips.</td>
      <td>Semiconductor<br>China<br>Revenue<br>Investment<br>Technology</td>
      <td>389.45</td>
      <td>37.02</td>
    </tr>
  </tbody>
</table><script src="static/tablesort.min.js"></script><script src="static/tablesort.number.min.js"></script><script>new Tablesort(document.getElementById("container"));</script></body></html>